FDA’s New Rare Disease Innovation Hub may accelerate rare liver disease treatment – Pediatric & Rare Liver Diseases News
Ipsen Pharmaceuticals has just shared exciting news for rare liver disease patients with cholestasis.
Available Today! New Patient Assistance & Provider Resources – Fatty Liver Disease News
Trauma-informed, patient-led consultations to build trust and enhance medical care are important to clinical care for liver health, Dr. Julia Wattacheril, Director of the MASLD Program at Columbia’s Center for Liver Disease and Transplantation, has emphasized.
Global Liver Institute and National Alliance for Caregiving Provide Recommendations to the Centers for Medicare & Medicaid Services and Centers for Medicare and Medicaid Innovation’s Increasing Organ Transplant Access (IOTA) Model
Based on our shared knowledge and experience, Global Liver Institute and National Alliance for Caregiving are proud to collaborate in providing recommendations to CMS and the Centers for Medicare and Medicaid Innovation (CMMI) that we believe will improve the proposed Increasing Organ Transplant Access (IOTA) Model
Obesity legislation on the move, GLI continues to fight for access to NASH/MASH treatments – Liver Health Policy Update
The House Ways and Means Committee marked up obesity legislation, moving the ball forward for Congress to act on coverage for Medicare beneficiaries. GLI solicits signatures on a petition to insurers to provide access to NASH/MASH treatment.
New this month: Copayment assistance for certain genetic/metabolic diseases and a second-line PBC therapy! – Pediatric & Rare Liver Diseases News
We are honored to have had the opportunity to represent the rare liver diseases community at the Alpha-1 Foundation National Conference in Miami, Florida. The weekend was filled with transformative research and thought-provoking conversations.